Professor David Price’s talks at ADVENT, 2019
Professor David Price discusses the need to minimize oral corticosteroid (OCS) use in patients with severe asthma. Overexposure to OCS can result in several short-term and long-term side effects, including diabetes and osteoporosis.
Dr. William Busse, Dr. Monica Kraft and Professor David Price share their insight on the current opportunities in the management of uncontrolled persistent asthma.
Professor David Price’s interview with Dr. Enrico Heffler, 2019
Professor David Price discusses the International Severe Asthma Registry (ISAR), an initiative by OPRI to create a worldwide database of severe asthma patients.
Rhinology Future Debates, 2017
Professors David Price, Oliver Pfaar and Glenis Scadding talk about whether asthma prevention can be achieved through allergen immunotherapy.
Professor David Price discusses the need for inhaled corticosteroids when treating asthma, the importance of adhering to the prescribed treatment regimen, and how to minimize possible side effects. He also touches on the use of oral corticosteroids during asthma exacerbations.
Professors David Price, Thomas Casale, Claus Bachert and Jean Bousquet share their predictions on the future of asthma treatment.
How can the principles of precision medicine by implemented in primary care, what are the challenges, and how can GPs work with specialists to provide precision medicine? Professor David Price gives his insights.
Dove Medical Press, 2016
Professor David Price provides his expertise on how big database studies in COPD can address questions that cannot be addressed by randomised controlled trials, the benefits and limitations, and how they can be optimised.
European Respiratory Society, 2015
Are randomised controlled trials achieving the results we need for patients? Leading experts consider the value of real-life evidence and whether it can enhance existing guidelines.
Dove Medical Press, 2011
A video abstract of the rapid communication paper “Physicians’ attitudes towards combination therapy with inhaled corticosteroids therapy with inhaled corticosteroids and long-acting β2-agonists: an observational study in UK specialist care” conducted by Professors Mike Thomas, John Haughney and David Price. Presented by Professor Mike Thomas.